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Tuberculosis (TB) is a leading cause of death globally. Natural history studies show that young children are at particularly high
risk of progression to active TB and severe, disseminated disease following infection. Despite this, high-quality regional and global
surveillance data on the burden of childhood TB are lacking. We discuss the unique aspects of TB in children that make diagnosis
and therefore surveillance challenging; the limitations of available surveillance data; other data which provide insights into the
true burden of childhood TB. Improved surveillance is among the key research priorities identiﬁed for childhood TB, but progress
to date has been slow. Recent advances in TB diagnostics, and standardized clinical diagnostic guidelines and case deﬁnitions, all
provide opportunities for new strategies to improve surveillance. Better-quality data on the burden and trends of childhood TB
will inform and improve both public health policy and clinical practice.
1.Introduction
Three main challenges currently hamper eﬀorts to control
tuberculosis (TB) globally. Firstly, the ability to identify
and diagnose cases remains suboptimal and is particularly
poor among children and human-immunodeﬁciency-virus-
(HIV-) infected individuals, with direct implications for the
availability and quality of surveillance data in these groups.
Secondly, there is a need for better (particularly shorter)
treatment regimens to improve individual case management
and to prevent and control the emergence and spread of
drug resistant strains. Thirdly, the search is still on for better
tuberculosis vaccines to provide more complete and longer-
lasting protection against active TB. Success in all three
areas is likely to be required to achieve the Stop TB goal to
eliminate TB as a public health problem by 2050 [1, 2]. This
paper addresses the ﬁrst of these challenges and focuses on
the need and potential strategies to improve diagnosis and
thereby surveillance of childhood TB in low-resource, high-
burden settings.
In 2009 an estimated 9.4 million cases of TB occurred
worldwide, equivalent to an annual global incidence of
137 per 100,000 population [3]. In the same year, 1.7
million deaths were attributed to tuberculosis [3]. TB
remains second only to HIV as a leading infectious cause
of death globally [4]. Global estimates of the causes of
death among children have also been derived [5, 6], and the
latest estimates based on data from 2008 are illustrated in
Figure 1 [4]. Given the overwhelming burden of tuberculosis
among the population as a whole and the well-documented
vulnerability of young children to active TB including the
severe and fatal forms of the disease [7], it is perhaps
surprising that TB does not feature among the leading
causes of death in children. Protection aﬀorded by Bacille
Calmette Gu´ erin (BCG) vaccination among infants and
young children, particularly against disseminated TB and
TB meningitis, provides one important explanation for this
apparent discrepancy [8]. However, even in this group the
protective eﬃcacy of BCG is suboptimal, and the best
available estimates suggest a high global burden of childhood
TB despite wide-scale neonatal BCG vaccination within the
Expanded Programme of Immunization [9]. To reconcile
these data requires a clear understanding of their limitations
and the underlying challenges of TB diagnosis in children.2 Journal of Tropical Medicine
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Figure 1: Causes of death among children under 5 years of age (data from [6]).
2.Diagnosisof Childhood TBand
Implications for Surveillance
The pathophysiology, clinical presentation, and investigation
of TB in children diﬀers from that in adults due to a
combination of immunological, anatomical, and epidemi-
ological factors, all of which make diagnosis considerably
more challenging [10]. Young children are at much higher
risk of progression to active TB following infection [7].
Larger inocula due to prolonged close contact with adults
in the household from whom they frequently acquire their
infection might contribute to this higher risk [11, 12], but
age-related diﬀerences in both innate and adaptive immune
responses to TB are thought to be the most important
determinants of their increased vulnerability [13]. Although
poorly understood, a less robust immune response is also
likely to underlie the paucity of lung cavitations in young
children with TB, in stark contrast with the classic picture of
adult pulmonary TB in which large numbers of bacilli may
“spill” from the cavities into the airways. Whatever the exact
mechanisms, important consequences of these diﬀerences
in host immunity include relatively fewer bacilli, particu-
larly in clinical specimens (“paucibacillary” disease), and
an increased propensity for disseminated, extra-pulmonary
disease in young children [10].
This in turn has implications for diagnosis since speci-
m e nc o l l e c t i o ni so f t e nm o r ed i ﬃcult from extra-pulmonary
sites, especially in low-resource settings, and low numbers
of bacilli greatly reduce the sensitivity of both smear
microscopy and mycobacterial culture. Anatomical diﬀer-
ences limit access to appropriate respiratory specimens in
childhood pulmonary TB, too, since smaller airways and less
tussive force limit a child’s ability to expectorate sputum,
necessitating more invasive and labour intensive methods
of specimen collection such as sputum induction or gastric
aspiration [14]. Immune-based diagnosis using tuberculin
skin testing (TST) or newer interferon gamma release assays
(IGRAs) is limited by poor sensitivity and speciﬁcity [15].
Furthermore, although they are recommended components
of the TB diagnostic workup for children where available, in
practice TST, gastric lavage and sputum induction are often
not available in high-burden settings due to limited training,
a lack of the basic equipment and consumables required
[16, 17], very low yield in the absence of mycobacterial
culture facilities [14], and cost [18, 19]. IGRAs remain far
tooexpensiveandcomplexforuseatthepointofcareinlow-
resource settings.
In the absence of a reliable gold standard and lack-
ing resources for further investigations in most settings,
diagnosis therefore usually has to rely on clinical case
deﬁnitions. To compound the problem, clinical diagnosis
is also more challenging in children, since the clinical
and radiological features of childhood TB overlap those
of other common childhood diseases, particularly where
HIV and malnutrition—two of the most important risk
factors—are endemic [20]. Several clinical algorithms have
been proposed, but although they continue to be widely
promoted, most have not been validated in the settings
in which they are used [21]. The net result is frequent
disease misclassiﬁcation that severely limits the quality of
both clinical care and surveillance data.
3.AvailableSurveillanceDataand
Burden of Disease Estimates
The main source of global surveillance data for childhood
TB comes from notiﬁcation data collected by National
Tuberculosis Programmes (NTPs) under the WHO DOTS
strategy [3]. However, both the quantity and the quality of
DOTS notiﬁcation data relating to childhood TB are limited.
Until recently data from children were aggregated in a single
category (<15 years) [22], ignoring important age-related
diﬀerences in disease incidence between preschool, school
age,andadolescentchildren.Thisreﬂectedthelowerpriority
traditionally aﬀorded to children by the DOTS strategy,
which understandably prioritizes detection and treatment
of smear positive pulmonary cases that contribute most
to propagation of the epidemic but occur predominantly
in adults. One consequence is a lack of data on age-
related trends among children that might help reﬁne burden
of disease estimates or aﬀord additional insights into the
eﬀects of the HIV epidemic or other epidemiological risk
factors on disease presentation or transmission patterns.
The WHO recommendation in 2006 for NTPs to reportJournal of Tropical Medicine 3
aggregated data for children in at least two categories (0–
4 years and 5–14 years) was a welcome step in the right
direction [19]. Nevertheless, severe limitations still exist in
the quality of available TB notiﬁcation data for children
due to frequent misclassiﬁcation arising from the very real
diagnostic challenges highlighted above, a lack of resources
for active case ﬁnding through contact tracing in most
settings, as well as limitations in the notiﬁcation process
itself. A recent study from South Africa demonstrated
signiﬁcant undernotiﬁcation of TB cases [23], and even in
Europe 1 in 5 children with TB are not notiﬁed [24], so
the situation is likely to be considerably worse in less well-
resourced settings. Perhaps reﬂecting all these problems with
the available data, WHO estimates of the global TB burden
do not currently include a breakdown of the disease burden
in children [3].
To date the best available published estimates of the
global burden of childhood TB have been derived by
combining DOTS notiﬁcation data for smear positive TB
with age-speciﬁc estimates of the proportion of the total
number of cases that are smear positive [9, 25]. These
estimates suggest there were approximately 900,000 new
cases of TB in children in 2000, which represented about
11%ofthetotalglobalburden[9].Thesearecrudeestimates,
however, due to the inherent limitations of the data on which
they are based. Even the proportion of childhood TB cases
which one might expect to be smear positive (on which
these estimates rely) is not straightforward to ascertain in
the absence of a reliable gold standard for diagnosis since it
requires knowledge of the total number of childhood cases in
a particular setting; furthermore, this proportion may vary
geographically or temporally with the prevalence of HIV
infection, malnutrition, or other risk factors.
Better-quality surveillance data are available from many
industrialized, low-burden settings [26, 27], where they
are underpinned by stronger health systems with better
diagnostic facilities and active case ﬁnding through routine
contact tracing. Burden of disease estimates from some
high-burden communities are also available and suggest
that children may account for approximately 20% of the
total caseload in such settings [28]. In one frequently cited
study based on oﬃcial notiﬁcation data from two urban
settings in Cape Town, South Africa, children accounted
for almost 40% of the total caseload over a 10-year period
[29]. In the absence of a standardized case deﬁnition in this
study, it is unclear whether this reﬂects the true potential
burden of childhood TB in settings where deteriorating
socioeconomic conditions drive high TB transmission rates,
or a tendency towards overdiagnosis by clinicians aware of
the high TB incidence combined with the poor performance
of available diagnostic tools and the potentially devastating
consequences of not treating a child with TB. A prospective
observational study of childhood TB in a very similar urban
setting in Cape Town suggested children accounted for about
15% of all TB cases [30]. However, the number of published
studies is small, and they derive from a minority of countries
that may not be representative of the overall picture.
The need for better-quality surveillance data from dif-
ferent communities and underpinned by improved case
deﬁnitions was therefore recognized as among the leading
research priorities for childhood TB in the WHO’s Research
Agenda for Childhood Tuberculosis [28]. There has been very
limited progress in this area, however. A PubMed literature
search performed on 14 October 2011 using the MeSH and
text search terms “tuberculosis” or “TB,” plus “child” or
“children” and “incidence” or “prevalence” identiﬁed only
15 studies presenting population-based data on the disease
burden of childhood TB since the report’s publication 5
y e a r sb e f o r :5 ,8 ,a n d2f r o mh i g h -[ 26, 27, 31–33], middle-
[34–41] and low- [42, 43] income countries, respectively.
There were no studies from any low- /middle-income or
high-TB-burden countries [3] that met the basic criteria
for prospective community incidence studies set out in the
WHO report [28].
In the absence of good-quality surveillance data, other
data sources may also be used to inform burden of dis-
ease estimates. Historical data from Europe correlating the
incidence of childhood TB disease with the annual rate
of tuberculosis infection (ARTI, derived from tuberculin
surveys) has been extrapolated to estimate childhood TB
incidence in modern communities in whom the population
structure and ARTI is known [44]. Interesting data also
come from pneumonia aetiology studies among children,
some of which have found active TB in 8–15% of children
with acute pneumonia [45, 46]. This may be particularly
pertinent to the question of hidden childhood TB mortality,
since pneumonia is responsible for the largest proportion of
deaths in children under 5 years (Figure 1). Autopsy data
are scarce, but a study in Zambia prior to the availability
of antiretroviral therapy or widespread use of cotrimoxazole
prophylaxis found active TB in 26% HIV-negative and 18%
HIV-positivechildrenwhodiedfrompneumonia[47].These
ﬁndingscallforsimilarstudiesinothersettingstoinvestigate
their generalizability.
4. Opportunities andStrategies for the Future
More robust estimates of childhood TB incidence and its
contribution to childhood mortality will depend critically
on improved surveillance in a wide range of settings.
Rigorous implementation of existing guidelines for contact
investigation among children [19] would improve active
case detection as well as providing real clinical beneﬁt
through identiﬁcation or earlier diagnosis and treatment of
many cases. Diagnosis remains the fundamental challenge,
but recent progress in this area provides opportunities to
improve case ascertainment and reduce disease misclassiﬁca-
tion. Standardized case deﬁnitions are key, so the publication
by the WHO of guidance on the investigation and diagnosis
of childhood TB including case deﬁnitions for smear positive
and negative pulmonary disease is an important step [19].
Further research to build on these case deﬁnitions and
to incorporate them into validated diagnostic algorithm(s)
based on high-quality evidence from a range of settings—
as has been done with some success for TB in HIV-positive
adults [48]—would oﬀer beneﬁts for both surveillance and
clinical care. Consensus deﬁnitions of childhood intratho-
racictuberculosisdraftedbyaninternationalpanelofexperts4 Journal of Tropical Medicine
for research purposes have recently been submitted for
publication (Stephen Graham, personal communication).
Ideally diagnosis should be supported by the best avail-
able methods for specimen collection and microbiological
conﬁrmation of M. tuberculosis. While this is unlikely to
be feasible in most low-resource, rural settings, research
gains slowly being translated into clinical practice do provide
an opportunity to develop heightened surveillance in some
centres—ideally linked to existing TB prevalence surveys or
studies of TB incidence among adults, in order to place
in context and maximize the scientiﬁc and public health
beneﬁts of the epidemiological data they generate.
The same sites could be used to assess and monitor the
local performance of more basic clinical case deﬁnitions and
diagnostic algorithms. Sputum induction has been shown
to be well tolerated, safe, and more sensitive than gastric
aspiration for diagnosis of pulmonary TB in children and
has the added advantage that it can be performed at a
single outpatient visit [14]. Although uptake of the method
has been slow in high-burden settings, it is slowly being
adopted in some urban centres and might be combined with
gastric aspiration at the same visit to further increase TB
culture yield [49]. Mycobacterial culture facilities are also
required if the full beneﬁt of improved specimen collection
is to be realized, but progress is also being made on this
frontbytheStopTBPartnershipGlobalLaboratoryInitiative
(http://www.stoptb.org/wg/gli/)[ 50, 51]. Although these are
likely in the medium term to remain restricted to a few
urban referral centres in many developing countries, other
developments in laboratory diagnosis might yet oﬀer the
possibility of expanding access to high-quality microbiologi-
cal diagnosis in low-resource, high-TB-burden settings.
The Microscopic Observation Drug Susceptibility
(MODS) and Thin Layer Agar (TLA) microcolony culture
techniquesprovidecultureanddrugsusceptibilityresultsata
fraction of the cost of commercial liquid culture systems and
donotrequireexpensivebiosafetylevel3laboratoryfacilities,
but are relatively labour intensive and require signiﬁcant
training [52]. More recently the Xpert MTB/RIF automated
real-time PCR assay, which requires minimal training and
infrastructure but is more expensive, has demonstrated
modest sensitivity for diagnosis of culture positive TB in
children [53]. All require further research to assess their
performance and cost eﬀectiveness in a range of settings.
The beneﬁts of improved childhood TB surveillance are
many. At a public health level, good-quality regional and
global data are critical to understand the causes of childhood
illness and death, thereby informing policy decisions and
priorities. Disease visibility is key to ensure appropriate
investment in prevention and control strategies and will also
be important to monitor the impact of new TB vaccines in
the future. In addition, since TB in a child must by deﬁnition
reﬂect recent infection (within the lifetime of the child) and
in most cases occurs within a year following infection [7],
the incidence of TB in children and their M. tuberculosis
isolates provide a useful window on current transmission
dynamics within a community, including transmission of
drug resistance strains. Beneﬁts to clinical care might be
expected due to improved case ﬁnding, standardization
of case deﬁnitions, local validation, and/or adaptation of
diagnostic algorithms utilizing data from sentinel sites with
access to more advance diagnostic facilities, and a greater
awareness of the burden and diagnostic algorithms among
clinicians. Children remain among the most vulnerable to
this common and all too often devastating disease. A better
understanding of the size of the problem will be essential to
any public health strategy to control childhood TB.
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